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Abstract
Premature infants are at high risk of neonatal brain injury due to poor cerebrovascular
regulation, leading to periods of dangerously low cerebral blood flow (CBF) and possible
injury. However, there are currently no established bedside methods of monitoring CBF to
alert the intensive care staff to cerebrovascular dysfunction. Diffuse correlation spectroscopy
(DCS) is an emerging noninvasive optical technique for monitoring relative CBF. I developed
a stand-alone DCS method of monitoring absolute CBF by incorporating a quantitative
dynamic contrast-enhanced (DCE) technique. This required modifying a DCS system to
capture multi-distance data to measure the tissue optical properties and to perform DCE
experiments. The feasibility of the technique was assessed by measuring CBF in piglets under
three flow conditions. For validation, the tissue optical properties were compared to
measurements from time-resolved near-infrared spectroscopy (NIRS). Across 7 animals, a
strong linear correlation was observed between CBF values derived using the two sets of
optical properties at baseline (R2=0.95), hypercapnia (R2=0.83) and hypocapnia (R2=0.88).
These results demonstrate that the developed DCS system provided the unique ability to
provide real-time monitoring of absolute CBF.

Keywords
Diffuse correlation spectroscopy, NIRS, Optical diagnostics, medical imaging, spatially
resolved NIRS, bolus tracking, neuromonitoring, neonates.
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Chapter 1

1

Introduction

This chapter provides an overview of biomedical optics as applied to brain monitoring in
the neonatal intensive care unit and the limitations of current methods. The principles of
near-infrared spectroscopy (NIRS) and the methodology employed to measure cerebral
blood flow (CBF) are outlined. Lastly, diffuse correlation spectroscopy (DCS), which is
the focus of my thesis is presented.

1.1

Clinical Significance

According to the Canadian Institutes of Health Research, of the 390,000 babies who are
born in Canada each year, nearly 8% are preterm births (less than 37 weeks of gestation).
Preterm birth is associated with two-third of infant deaths in Canada. In addition, preterm
infants are at a higher risk of brain injury, with 40-50% developing long-term cognitive
and behavioral deficits and 5-10% developing major disabilities such as cerebral palsy [1].
The major forms of preterm brain injury are associated with damage to the cerebral
vasculature. One of the most common is intraventricular hemorrhage (IVH), which arises
in one-third of very preterm infants [2][3]. It refers to internal bleeding from the germinal
matrix into the ventricles and adjacent brain tissue. In more than 90% of the cases, IVH
occurs within the first 3 postnatal days, and it is a major risk factor for death and poor
neurodevelopmental outcome. Despite advances in neonatal care, it remains a significant
problem. The other major form of neonatal brain injury is periventricular leukomalacia
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(PVL), which refers to ischemic injury in the white matter near the lateral ventricles [4].
The vulnerability of the preterm brain to these types of injury is believed to be a
combination of cerebrovascular risk factors coupled with systematic factors, particularly
the high incidence of hypotension. Cerebral autoregulation (CA) refers to the ability to
maintain normal CBF despite fluctuations in arterial blood pressure. It is known that CA is
impaired in preterm brain due to the immaturity of the cerebral vessels [5][6]. In addition,
CBF is extremely low in the preterm brain [7], and infants who developed brain injury have
lower CBF [8]. It is likely that the combination of these two factors makes the preterm
brain susceptible to brain injury; i.e., hemorrhage during periods of hypertension and
ischemia when blood pressure decreases.
The seminal study conducted by Soul et al. in 2007 used NIRS to show that cerebral
pressure-passivity is common in the preterm brain [9]. This was performed by correlating
changes in tissue oxygenation, used as an indirect marker of CBF, to fluctuations in arterial
blood pressure. Their results demonstrated that 87 of the 90 preterm infants had periods of
cerebral pressure-passivity; however, they did not find a correlation to brain injury. One
possible explanation is that they only looked at relative CBF changes and were not able to
define the true magnitude of changes in blood flow by monitoring tissue oxygenation.
Therefore, to overcome the low predictive power of this technique and improve sensitivity,
the ideal method should be able to quantify CBF in order to determine how low flow drops
during pressure fluctuations. This would be analogous to assessing brain injury associated
with ischemic stroke in adults since severity of injury depends on both the duration and
value of ischemic flow[10].

3

1.2 Near Infrared Spectroscopy
Near infrared spectroscopy is a non-invasive optical technique used primarily to monitor
tissue oxygenation. It utilizes light in the near-infrared region (700-1000 nm), known as
the optical window[11]. Due to low absorption in this band, light can penetrate deeper into
tissue compared to visible light, which has a penetration depth of only a few millimeters.
The interaction of light with tissue is by scattering and absorption. The latter refers to the
transfer of energy to an absorbing molecule by excitation of a vibrational state. That is, if
the frequency of a photon equals the energy that is required by the molecules to transition
to a higher energy state, then the photon is absorbed, otherwise it is scattered (i.e., reemitted in another direction). Scattering and absorption are characterized by their
respective exponential coefficients: s for scattering and a for absorption. These
coefficients are the reciprocal of the distance a photon typically travels before it is either
scattered or absorbed. In the NIR range, s is approximately 100 times greater than a,
reflecting the low absorption and high scattering properties of tissue.
The first person to arithmetically define absorption in a non-scattering medium was Pierre
Bouguer. He discovered that in a homogeneous medium the decrease in light intensity is
related exponentially to a and the distance between source and detector (ρ):
𝐼 = 𝐼𝑜 𝑒 −𝜇𝑎𝜌

1-1

where Io is the source light intensity and I is the measured light intensity. In 1852, August
Beer observed that light absorption was proportional to the concentration (ci) of a
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Figure 1-1: Molar extinction coefficients for the three main endogenous
chromophores: oxyhemoglobin (HbO2), deoxyhemoglobin (HHb) and
water
chromophore (light-absorbing molecule) in the medium. In the presence of multiple
chromophores, the absorption coefficient can be written as:
𝜇𝑎 (λ) = ln(10) ∑ 𝜖𝑖 (λ)𝑐𝑖

1-2

𝑖

where ε is the wavelength-dependent extinction coefficient of the ith chromophore. Of all
the chromophores in tissue, the main absorbing chromophores of NIR light are
oxyhemoglobin, deoxyhemoglobin and water. Their wavelength-dependent absorption
characteristics are illustrated in Figure 1-1.
Figure 1-1 highlights that the dominant tissue chromophore in the NIR region is
hemoglobin, and the optical window is defined by the increase in absorption of hemoglobin
at shorter wavelengths and by water at longer wavelengths. In principle, the concentration
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of the main chromophores can be determined by applying Equation 1-2 to absorption data
obtained at different wavelengths. However, the challenge to applying this approach to
tissue is the much larger effects of light scattering.
In tissue, scattering is forward directed; however, the photon direction quickly becomes
isotropic. This occurs at a distance given by ~1/s, where s is defined as the reduced
scattering coefficient and is defined as:
μ𝑠 (λ) = (1 − g(λ)). μ𝑠 (λ)

1-3

where g is the anisotropy factor, which is the average cosine of the scattering angle. It is a
measure of the directionality of elastic scattering (i.e. scattering efficiency) and varies
between -1 and 1.
Since tissue is a highly scattering medium, due to the presence of many scattering particles
and changes in refractive indices within a small volume (1 mm3), the number of scattering
events is much higher than absorption interactions (µs >> µa). The main scattering
constituents of a NIR photon, listed in order of scattering frequency, are lipoprotein
membranes, mitochondria, red blood cells (RBCs), and other cellular components. These
tissue scattering particles can be grouped into two categories: static and dynamic scatterers.
The difference is the variation in phase of the interacting photon over time. Although
scattering events occur more often with static tissue constituents, such as lipoprotein
membranes and mitochondria, the phase change is time invariant, and the major
contribution to the temporal phase fluctuations of a NIR photon is due to moving RBCs
[12][13]. The variation in phase due to motion is an important phenomenon that can be
exploited to measure flow.
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1.3 Propagation of Light in Tissue
In biological tissues, scattering processes play a substantial role in the propagation of light.
These scattered radiations contain information about tissue structural elements, their
orientation, optical properties, and other parameters. To extract information and interpret
experimental results, appropriate optical models for tissue based on radiation propagation
are required.

1.3.1

Radiative Transfer Equation

Typically, the propagation of an electromagnetic wave in a medium can be solved using
Maxwell’s equations; however, in tissue the occurrence of many scattering events makes
obtaining solutions to Maxwell’s equations intractable. Due to this, simplification and
different assumptions are needed to explain light propagation in tissue. Thus, when using
Maxwell’s equation, we approximate the solution by looking at light propagation as a
stream of photons and by characterizing the individual photon pathlengths with radiative
transport theory [14]. As radiance (the power of light emitted in a direction per unit solid
angle [W/cm2/sr]) travels within tissue, the radiative transport equation (RTE)
mathematically models energy conservation by describing the interactions between
particles and radiation:
1𝜕
𝐿(𝑟, 𝑡, Ω) + 𝑆̂∇𝐿(𝑟, 𝑡, Ω) + (𝜇𝑎 +  𝜇𝑠 )𝐿(𝑟, 𝑡, Ω)
𝑣 𝜕𝑡
=  𝜇𝑠 ∫ 𝐿(𝑟, 𝑡, Ω)𝑃(Ω, Ω՜) ∂ Ω՜ + S(𝑟, 𝑡, Ω)
4𝜋

1-4
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where L(r,t,Ω) is the radiance in a medium at position r, traveling in direction Ω, at time t.
The scattering phase function, P(Ω, Ω՜), represents the probability of scattering into a
direction Ω՜ from direction Ω. The speed of light in the medium is v, the source term is
S(r,t,Ω), and dΩ՜is the solid angle around Ω.

In an infinitesimal volume, the above equation accounts for the energy losses due to
scattering and absorption, and energy gains because photon scattered into the volume and
due to a light source. Even though this equation simplifies the Maxwell’s equation, it is
still complex and does not have analytical solutions. Therefore, further approximations are
needed to solve the radiative transfer equation.

1.3.2

Diffusion Approximation

The diffusion approximation (DA) is one of the most widely used approximations to the
radiative transfer equation. It is valid for conditions where the scattering length (ls=1/μs) is
small compared to the distance of propagation. The standard approach to the diffusion
approximation is through the PN approximation, in which all angular dependent quantities
(i.e. radiance, phase function, and light source) in a spherical Legendre series is truncated
at the first order. The DA holds when the PN assumes that the scattering coefficient is larger
than the absorption coefficient, the observation point is far from the boundary of the
medium, light is unpolarized, and the timescale is sufficiently long.
Thus, the photon fluence rate, which linearly combines the power of the photons incident
on the sphere of cross-sectional area L [W/cm2] can be written as:
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𝜑(𝑟, 𝑡) = ∫ 𝐿((𝑟, 𝑡, Ω) 𝑑Ω

1-5

and the photon flux, J(r,t), defined as the vector sum of the radiance emerging from an
infinitesimal volume [W/cm2] is given by:
𝐽(𝑟, 𝑡) = ∫ Ω. 𝐿((𝑟, 𝑡, Ω) 𝑑Ω

1-6

The radiance from PN approximation can also be derived independent of direction and is
given by:
𝐿((𝑟, 𝑡, Ω) =

1
3
𝜑(𝑟, 𝑡) +
𝐽(𝑟, 𝑡)Ω
4𝜋
4𝜋

1-7

By combining the photon fluence with the radiative transfer equation and integrating over
the solid angle, we get the continuity equation of the fluence rate:
1𝜕
𝜑(𝑟, 𝑡) +  ∇𝐽(𝑟, 𝑡) + 𝜇𝑎 (𝑟, 𝑡)𝜑(𝑟, 𝑡) = S(𝑟, 𝑡)
𝑣 𝜕𝑡

1-8

The relationship between fluence rate and flux rate can be defined by Fick’s law, which
relates the diffusion of photons in a scattering medium by:
𝐽(𝑟, 𝑡) = −

𝐷(𝑟, 𝑡)
∇𝜑(𝑟, 𝑡)
𝑣

1-9

D(r,t) is the photon diffusion coefficient and is defined as:
𝐷(𝑟, 𝑡) =

𝑣
3(𝜇 ′

𝑠

1-10

+ 𝜇𝑎 )

Thus, in tissue the radiance of the RTE equation by photon fluence (φ(r,t)) can be described
by the DA. It is derived by substituting Fick’s Law into the fluence continuity equation to
get:
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𝜕

(𝐷(𝑟, 𝑡)∇2 − 𝑣𝜇𝑎 (𝑟, 𝑡) −  𝜕𝑡) 𝜑(𝑟, 𝑡) = −𝑣𝑆(𝑟, 𝑡)

1-11

The above equation can be used to characterize the paths travelled by photons that
undergoes isotropic scattering, and unlike the RTE, analytical solutions are known for
specifics geometries.

1.3.3

Modified Beer-Lambert Law

Modified Beer-Lambert law (MBBL) is an empirical model that is widely used to analyze
reflectance signal in NIRS applications. It uses continuous-wave diffuse optical intensity
measurements to derive changes in tissue optical property. As compared to the BeerLambert law, which only accounts for tissue absorption, the MBBL accounts for light
scattering by using the mean pathlength travelled by the photons through the highly
scattering medium as the best estimate for the actual photon pathlength. The Modified
Beer-Lambert law is derived from the first order Taylor expansion of the sample optical
density (OD):
𝑂𝐷0 ≈  𝑂𝐷0 + (

𝜕𝑂𝐷0
𝜕𝑂𝐷0
) ∆𝜇𝑎 + (
) ∆𝜇𝑠′
𝜕𝜇𝑎
𝜕𝜇𝑠′

1-12

where OD0 is the baseline optical density, defined as the negative logarithm of the ratio of
transmitted to incident light intensity:
𝐼𝑡
𝑂𝐷 = − log [ ] = 𝜇0 𝜌
𝐼0

1-13

where I0 is the incident light, It is the transmitted light, ρ is the sample length and OD is
proportional to the sample absorption coefficient (µa). The partial derivatives are evaluated
at baseline condition, i.e. µa = µa0 and µs = µs0 and the differential changes in absorption
and scattering are denoted by ∆µa ≡ µa(t) − µa0 and ∆µs ≡ µs (t)− µs0.
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Based on these approximations, changes in optical density from baseline are given by:
𝐼𝑡
𝜇𝑎0
〈𝐿〉
(𝑡)
𝑂𝐷 = − log ( ) ≈
∆𝜇𝑎
+ ( ′0 ) 〈𝐿〉∆𝜇𝑠′ (𝑡) ≈ 〈𝐿〉∆𝜇𝑎 (𝑡)
𝐼0
𝜇𝑠

1-14

The differential pathlength (⟨L⟩) is the mean pathlength that diffusing photons travel within
the medium from source to detector and is defined as:
〈𝐿〉 ≡

𝜕𝑂𝐷0
𝜕𝜇𝑎

1-15

Thus, using the above expansion, we can derive a Modified Beer-Lambert law for analysis
of NIRS reflectance signal [15].

1.4 Near-Infrared Techniques
In clinical applications, NIRS data are acquired in either transmission or reflectance mode.
In the former, the NIR light source is placed on one side of the medium, and the detector
on the other side. Light is shone through the sample and collected after being scattered and
absorbed. In reflectance mode, the NIR source and detector are placed on the same surface
of the sample (such as the skin for in situ applications) and reflected photons collected are
due to the high number of scattering events within the turbid medium. The latter technique
is more common in neurological studies since the size of the human head makes it
infeasible to collect information in transmission mode. Various NIR methods have been
developed for this purpose and are described below.
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1.4.1

Continuous-Wave NIRS

Continuous-wave (CW) NIRS is the simplest type of in vivo NIRS techniques, since it only
measures the reduction in light intensity due to absorption and scattering in the medium.
Generally, CW NIRS uses the modified Beer-Lambert Law to model light attenuation and
changes in a can be derived assuming scattering properties of the medium remain constant.
Quantification of the concentration of the various chromophores is difficult with this
simple approach since the differential pathlength is unknown and must be either assumed
or measured by another method. [16]. Nevertheless, acquired attenuation data at multiple
wavelengths (such as using multiple light emitting diodes) or across the NIR spectrum
(using a broadband light source) can be used to monitor changes in the concentration of
chromophores [17].

1.4.2

Spatially Resolved NIRS

Spatially resolved spectroscopy (SRS) is a CW method involving the acquisition of light
intensity measurements at multiple source-detector distances [18][19]. For a semi-infinite
homogeneous medium having a source defined as r = 0 and a detector placed at r = rsd, the
detected light intensity, known as the diffuse reflectance, is defined by the DA:
1

2 2
2
𝑧0 𝑒𝑥𝑝 [−𝜇𝑒𝑓𝑓 (𝑧0 + 𝑟𝑠𝑑 ) ]
1
R 𝑑 (r𝑠𝑑 ) =
[𝜇
+
𝑒𝑓𝑓
1]
2
2𝜋
𝑧02 + 𝑟𝑠𝑑
2 )2
(𝑧02 + 𝑟𝑠𝑑

1-16

where z0 = 1/µsdescribes the depth at which the direction of the emitted light becomes
isotropic (i.e. entered the diffusion regime), and µeff is the effective attenuation coefficient:
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𝜇𝑒𝑓𝑓 ≡ √3𝜇𝑎 (𝜇𝑎 + 𝜇 ′ 𝑠 ) =  √3𝜇𝑎 𝜇 ′ 𝑠

1-17

For a large source-detector distance (i.e. rsd >> z0), the solution simplifies to:
2
2
ln[𝑟𝑠𝑑
R 𝑑 (r𝑠𝑑 )] = −𝜇𝑒𝑓𝑓 𝑟𝑠𝑑
+ ln (𝜇𝑒𝑓𝑓 +

1
2 ) + 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡
𝑟𝑠𝑑
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When 𝑟𝑠𝑑 >> 𝜇𝑒𝑓𝑓 the second term becomes a constant and a linear relationship is obtained
between rsd and ln[rsd2Rd(rsd)], and the -µeff gives the slope of the equation:
2
2
ln[𝑟𝑠𝑑
R 𝑑 (r𝑠𝑑 )] = −𝜇𝑒𝑓𝑓 𝑟𝑠𝑑
+ 𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡
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Thus, by plotting the intensities at different source-detector distance, we can get a direct
estimate of 𝜇𝑒𝑓𝑓, which can be used to estimate µa assuming a known value of µs

1.4.3

Time-Resolved NIRS

Time-resolved (TR) NIRS uses lasers capable of emitting ultrashort pulses of light (of the
order of picoseconds) and fast detectors capable of detecting the arrival of single reflected
photons through the medium. A histogram of photon arrival times is generated, called the
temporal point spread function (TPSF)[20][21]. It reflects the multiple different paths that
photons take through the medium due to scattering. However, the measured TPSF is also
influenced by the dispersion of light by the instrumentation. Therefore, the true distribution
of the photon times of flight (called the DTOF) through the medium can only be obtained
by removing the effects of the instrument response function (IRF) from the measured TPSF
(Fig 1-2). Assuming the IRF is properly characterized, then the tissue optical properties

13

(s and a) can be determined by modelling the DTOF by analytical solutions to the
diffusion approximation.

Figure 1-2: Measured IRF of the instrument and the measured dispersion of the
photon arrival time after the light interrogates the tissue (TPSF)

1.4.4

Frequency Domain NIRS

Frequency domain NIRS can be considered the frequency analog of TR NIRS. With this
approach, the light source is modulated at a known frequency, typically in the radio
frequency range, and a fast detector is used to measure the change in light intensity (both
DC and AC) as well as the phase shift between the emitted and detected light. The
absorption and scattering coefficients can be determined by applying the DA to the
measured phase shift and modulation amplitude in the frequency domain [22]. The
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capability to collect phase information is the key difference between CW and frequency
domain methods. However, phase measurements are inherently noisy, and frequency
domain approaches require calibration against a tissue-mimicking phantom with known
optical properties.

1.5 Dynamic Contrast-Enhanced NIRS to Measure CBF
Cerebral blood flow can be measured by NIRS using dynamic contrast-enhanced (DCE)
techniques that rely on injecting of an optical contrast agent into the systemic circulation.
The contrast agent acts as a blood flow tracer, whose transport through the
microvasculature is modeled by constructing a kinetic model and applying it to the time
dependent measurements of tracer concentration. The relationship relating the tissue
concentration of contrast agent to its arterial blood concentration is given by:
𝑡

𝐶𝑡 (𝑡) = 𝐶𝐵𝐹 ∙ ∫ 𝐶𝑎 (𝑡 − 𝑢). 𝑅(𝑢)𝑑𝑢
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0

where Ct(t) is the dye concentration in tissue as a function of time (t) measured by NIRS,
Ca(t) is the arterial blood concentration measured by a dye oximeter, and R(t) is the impulse
residual function, which represents the fraction of tracer in the tissue at time t, after an
idealized bolus injection at time t=0 of unit concentration. The function CBF·R(t) can be
extracted from the tissue and arterial ICG concentration curves by deconvolution. The
initial height is equal to CBF since by definition R(0) = 1. Although this method is
quantitative, it only provides a single CBF measurement and is therefore not suitable for
continuous monitoring [23].
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1.6 Diffuse Correlation Spectroscopy
Diffuse correlation spectroscopy (DCS) is an emerging non-invasive optical technique for
monitoring tissue blood flow, which is similar to conventional NIRS, but it has the
advantage of providing a continuous signal that is directly related to the movement of
scatterers in tissue. DCS works by measuring the temporal correlation of coherent NIR
light, which is dominated by the movement of red blood cells. It is an extension of dynamic
light scattering (DLS), which follows single scattering events and is only applicable to
optically thin samples. DCS, on the other hand, is a multiple scattering technique, which
applies the methodology of DLS to thick samples. Here, individual scattering events
combine to result in a net phase shift, which causes a decline in phase correlation. Because
the primary moving light scatterers in tissue are RBCs, the measured phase changes are
directly related to blood flow. However, DCS does not directly measure phase shifts, rather
it measures temporal intensity fluctuations of coherent light, which are characterized by
generating an autocorrelation function. In essence, faster moving RBCs lead to a more
rapid loss of phase coherence, which is characterized by a rapid decrease in an
autocorrelation function (Fig 1.2) [24][25].
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Figure 1-3: A) Schematic of a multiple light scattering event inside a tissue, where light
interact with the moving RBCs and is scattered, with the solid and dotted lines showing the
path the light takes at time t and later after delay at t+. B) Shows the intensity fluctuations
detected by the detectors. C) Schematic shows the phase decay calculated based on the
speed of the moving scatterers.

1.6.1

Intensity Autocorrelation and Correlation Diffusion Equation

In a scattering medium, the normalized temporal autocorrelation function of an electric
field (E(t)) is given by:
〈𝐸(𝑡) ∙ 𝐸 ∗ (𝑡 + 𝜏)〉
〈|𝐸(𝑡)|2 〉
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𝐺1 =  〈𝐸(𝑡) ∙ 𝐸 ∗ (𝑡 + 𝜏)〉
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𝑔1 = 

where,

is the diffuse electric field autocorrelation function,  is the autocorrelation delay time and
E(t+) is the electric field after a delay . In DCS, temporal intensity fluctuations are
measured rather than g1. The normalized intensity autocorrelation function, given by:
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𝑔2 =

〈𝐼(𝑡) ∙ 𝐼 ∗ (𝑡 + 𝜏)〉
〈|𝐼(𝑡)|2 〉
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where I(t) is the light intensity detected at the tissue surface at time t. This normalized
intensity autocorrelation function is related to g1(t) through the Siegert relationship:
𝑔2 = 1 + 𝛽|𝑔1 (𝑡)|2
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where β is the coherence factor of the detection system, which depends on the detection
optics and is inversely proportional to the number of detected light modes.
Analogous to characterizing changes in light reflectance through a turbid medium, G1 can
be modelled using the diffusion approximation [26] [27]:
(𝐷(𝑟, 𝑡)∇2 − 𝑣𝜇𝑎 (𝑟, 𝑡) − 𝑘𝐷2 (𝜏))𝐺1 (𝑟, 𝜏) = −𝑣𝑆(𝑟, 𝑡)
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where
2

𝑘𝐷2 (𝜏) = 3𝜇 ′ 𝑠 𝜇𝑎 + 𝛼𝜇 ′ 𝑠 𝑘02 〈𝑟(𝜏)〉
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accounts for the loss of correlation due to the motion of scatterers. <r()> is the meansquare displacement of the moving scatterers during a correlation time τ and is the
proportion of moving scatters (largely RBCs in tissue), k0 = 2πn/λ is the wavenumber of
light (λ is wavelength and n is the refractive index)[13]. In order to compute the g2(ρ,τ) to
estimate blood flow, an appropriate analytical model capable of mapping the tissue
geometry and the motion of the erythrocytes in the tissue is required to solve for the
correlation diffusion equation.
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1.6.2

DCS Models of Blood Flow ⟨r⟩

Since the orientations of the microvessels in the brain are fairly random, dynamic scattering
associated with red blood cells is commonly modeled as pseudo-Brownian motion. In this
model, the mean square displacement, <r()>, is equal to 6DB where DB is called the
effective diffusion coefficient [28]. Using this definition, the solution to G1(ρ,𝜏) for a semiinfinite homogeneous medium is given by:
3𝜇𝑠′ exp(−𝑘𝐷 𝑟1 ) exp(−𝑘𝐷 𝑟2 )
𝐺1 = 
[
−
]
4𝜋
𝑟1
𝑟2

1
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1

where, 𝑟1  =  [𝜌2  +  𝑧02 ]2 and 𝑟2 =  [𝜌2  +  (𝑧0 +  2𝑧𝑏 )2 ]2 . z0 is the effective depth of the
source and is defined as 1/µ́s, zb is the extrapolated boundary and is defined as
2D(1+Reff)∙(1−Reff)−1. D is the diffusion coefficient and Reff is the effective reflection
coefficient given by 0.493 for the refraction indices of tissue and air [24][29]. It is common
in DCS experiments to express the product αDB as a blood flow index (BFI), which has
units of cm2/sec.

1.6.3

DCS System

The DCS system consists of a long coherence length laser that emits continuous nearinfrared light at a particular wavelength. The output from the source is fed to a multimode
fiber to deliver the light to the tissue. A long coherence length laser ensures that the emitted
light is in phase for distances that are much greater than the typical photon pathlengths
within tissue. A single-mode or a few-mode fiber is used to collect the reflected light, which
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is directed to a suitable detector. Fast photon counting avalanche photodiodes, most
commonly a single photon avalanche photodiode (SPAD) are used. The detector’s output
is fed into a correlator board that computes the normalized intensity autocorrelation
function.
The most commonly used correlator board works on a multi-tau scheme, which was first
introduced by Schatzel in 1985 [30]. Multi-tau schemes were developed to decrease
computational load. The board takes the TTL signal to generate an autocorrelation function
using a large range of delay times, ranging from 10ns up to hours. The correlator consists
of registers (typically starting at 32 registers) with different bin width (T0), which double
after every few registers. When acquisition is initiated, a digital counter passes the photon
counts as TTL pulses which are collected in time bins of the first register. This value is
shifted to the right as each new value is updated from the left of the register. Each register
is updated based on their T0 value. Since T0 doubles every few registers, the updating time
for each register also varies with respect to T0. The temporal intensity autocorrelation
function is calculated before each shift and the autocorrelation function is continuously
averaged over the entire acquisition time t, whereas the delay time is the summation of all
the bin widths on the left of the register. Using this technique, the computational load is
greatly reduced as compared to the linear autocorrelator, but they do have limitations. For
DCS applications, the lack of flexibility to compute over selected delay times makes
hardware multi-tau correlators suboptimal since recorded correlation times are much
smaller than the fixed ranged on the correlator board [31].
Recently, the development of software-based correlators has been proposed in order to
provide a means of controlling the correlation times for DCS [32]. The approach feeds the
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output of a SPAD into a high-speed counting board (PCIe-6612 National Instruments),
which in turn is read by a high-level software program (LabVIEW) to compute
autocorrelation functions with sub-second resolution. The advantage of this approach
compared to a commercial hardware correlator, which measures correlation times over a
wide and fixed range (1µs-1s), is the ability to measure only those correlation times
relevant to blood flow (typically between 10 and 100 µs). Targeting the optimal range
greatly enhances the signal-to-noise ratio, thereby allowing measurements with
millisecond resolution [32].

1.7 Study Rationale
DCS is an emerging noninvasive optical technique for monitoring relative CBF, but it does
not provide a measure of absolute blood flow, making it difficult to assess if CBF drops to
ischemic levels. To convert the DCS signal into units of CBF, it has been combined with
DCE NIRS to estimate absolute flow. That is, a single value of CBF obtained using an
optical contrast agent can be used to calibrate the BFI data obtained by DCS [23]. This
approach requires combining two optical systems: NIRS for measuring CBF, and DCS for
monitoring BFI, which adds to the complexity and cost of the system. Therefore, it would
be advantageous to develop a stand-alone DCS system capable of monitoring absolute
CBF. This device could be used to establish ischemic threshold in preterm infants as
currently there is no means of determining the magnitude of CBF fluctuations in preterm
infants with impaired CA.
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1.8 Research Objective
The goal of my research work was to develop a portable system using DCS suitable for
continuous monitoring and quantification of cerebral blood flow in preterm infants. To
achieve this goal, the following objective were addressed:
1.

Develop a stand-alone DCS system that incorporates a software correlator
coupled to a multi-channel detection system in order to capture intensity and
correlation data at multiple source-detector distance.

2. Validate the ability of the multi-distance (MD) DCS system to measure tissue
optical properties in a neonatal animal model (piglets). Validation was performed
by independently measuring the optical properties using TR-NIRS.
3.

Demonstrate the ability of the system to track changes in CBF caused by altering
arterial carbon dioxide pressure (i.e. both low (hypocapnia) and high
(hypercapnia) conditions).
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Chapter 2

2

Methods

The motivation for monitoring cerebral hemodynamics in the NICU was provided in
Chapter 1. Ideally, the device should be portable and compact for bedside monitoring and
provide a means of assessing CBF considering the link between blood flow instabilities
and neonatal brain injury. This chapter outlines the development of a multi-distance DCS
system designed for this purpose. The key modification to the system was the replacement
of a hardware correlator with an in-house-developed software version. This enabled the
acquisition of multi-distance intensity measurements to measure the tissue optical
properties based on spatially resolved NIRS methodology. In addition, CBF was measured
by acquiring DCE absorption changes using indocyanine green (ICG) as an intravascular
contrast agent. By measuring absolute CBF, the DCS blood flow index could be converted
into units of blood flow, enabling DCS to monitor CBF without requiring a separate NIRS
system for the DCE experiments.
The experiments outlined in this chapter were conducted to test the sensitivity of the multidistance DCS system to changes in CBF. Experiments were conducted in newborn piglets
as the thickness of the extracerebral tissues (scalp and skull) is negligible, similar to
preterm newborns. CBF was altered by manipulating arterial carbon dioxide tension
(paCO2): elevated paCO2 (i.e., hypercapnia) to increase CBF and reduced paCO2 (i.e.,
hypocapnia) to decrease CBF. In addition, the optical properties were measured
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independently by TR-NIRS for comparison to measurements obtained by MD-DCS
system.

2.1 Animal Preparation
Animal experiments were conducted in accordance with the guidelines of the Canadian
Council of Animal Care (CCAC) and approved by the Animal Care Committee at Western
University. Newborn piglets (<10 days old, 3.02±1.37 kg, 4 females, 3 males) were initially
anesthetized with 5% isoflurane, which was reduced to 3% for surgical procedures and
maintained at 2-2.5% during the course of the experiment. Animals were tracheotomized
and mechanically ventilated on a mixture of 2 L oxygen and 2 L medical air (21% O2,
balance N2). Vital signs including heart rate (HR), end-tidal carbon dioxide tension,
respiratory rate (RR), and blood pressure were continuously monitored (SurgiVet, Smith
Medical, MN) via a femoral artery catheter. Arterial oxygen saturation was measured by a
pulse oximeter attached to the piglet’s right front hoof. Intermittent arterial blood samples
were collected via the femoral catheter for blood gas and glucose analysis (Radiometer,
ABL 80 FLEX CO-OX, Denmark). An ear and cephalic vein were catheterized for IV
access, which included injecting ICG injections (Sigma-Aldrich, Saint Louis, MO) and
infusing NaCl fluids (4 ml/kg/h). The piglet’s scalp was shaved and the piglet was placed
in a prone position within a plexiglass jig to help support a custom-made optical fiber probe
holder, which held the DCS and TR-NIRS probes to the scalp throughout the experiment.
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2.2 Experimental Procedure
The DCS optical fibers were positioned on the head at source-detector separations of 15,
20 and 25 mm. TR-NIRS optical fibers were placed parallel to the DCS holder, ensuring
that they interrogated the same brain region, at a source-detector distance of 30 mm.
Measurements from the two systems were acquired sequentially, with shutters placed in
front of the TR-NIRS and DCS lasers, as well as the TR-NIRS photomultiplier tube (PMT).
This prevented cross-talk between the two systems when collecting sequential data.
DCS and TR-NIRS data were acquired at each capnic level, starting with the baseline
condition (normocapnia). At each level, TR-NIRS and MD-DCS data were collected to
determine the tissue optical properties. In addition, DCE intensity data were collected with
the DCS system in order to quantify CBF. The procedure involved a bolus injection of ICG
(0.1 mg/kg in 1 ml of sterile water and dextrose used in equal ratio) into the ear vein,
followed by acquiring a series of intensity measurements at a temporal resolution of
300 ms. At the same time, the time-varying arterial concentration curve was measured by
a pulse dye densitometer (DDG 2001, Nihon Kohden, Tokyo, JP) attached to the right
forelimb.
During the transition between capnic levels, DCS data were continuously recorded to track
the dynamic changes in the BFI. Measurements were taken for 20 minutes, encompassing
a 5 minute period prior to CO2 manipulation and 15 minutes following. The DCE protocol
discussed above was performed at the end of each 20 minute period to measure CBF at the
new paCO2 value. Following each measurement, the animal’s CO2 level was returned to
baseline before transitioning to a new state. To achieve hypercapnia, the piglet was
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ventilated with 5.25% of CO2 (0.5 L O2 and 3.5 L CO2) in order to accomplish a rapid
change in capnic level, whereas hypocapnia was induced through hyperventilation to blow
off CO2. All experiments started at baseline and the order of hyper and hypocapnia was
randomized.

2.3 Instrumentation
2.3.1

Diffuse Correlation Spectroscopy

The DCS system consisted of a long coherence length (>5 m) continuous-wave laser
operating at 785 nm, with a maximum power output of 100 mW (DL-785-100-3S,
CrystaLaser, Reno, NV). The laser was coupled to a multimode fiber (NA = 0.22,
core = 400 µm, 4.7 mm outer diameter; Fiberoptics Technology, Connecticut, US) which
directed the light to the head. The reflected light was collected by three 2.5 m long singlemode fibers (SMF-28-J9, NA = 0.14, core = 8.2 µm, single-mode cutoff wavelength
= 1260 nm, Thorlabs, New Jersey, US) placed at 15, 20, and 25 mm source-detector
distance and mounted to the head using a custom-designed 3D-printed probe holder. Each
detection fiber was wrapped into a 15 cm coil to attenuate higher order modes by
converting them into non-propagating modes [33][23]. Light from the detectors was
received by a multi-channel single photon counting APD (SPCM-AQR-15-FC,
PerkinElmer Canada Inc, Quebec, CA), which fed TTL pulses into an edge-detecting
counter on a PCIe6612 counter/timer data acquisition board (National Instrument, Austin,
Texas). Photon counts were recorded and processed using in-house developed software
(LabVIEW, National Instrument and MATLAB) to generate intensity autocorrelation
curves (g2) (Fig 2.1).
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The advantage of this approach compared to commercial hardware correlators, which
measure correlation times over a wide and fixed range (1 µs – 1 s), is the ability to measure
only those correlation times relevant to blood flow (typically between 10 and 100 µs). DCS
measurements were conducted with a minimum baseline duration of 2 min at a temporal
resolution of 300 ms; g2 curves were computed using 40 delay time points (i.e. from 1 to
30 µs).

Figure 2-1: Software-based DCS system consisting of a 785 nm laser incident on the tissue
surface and detectors placed 15, 20, and 25 mm from the source. Emitted light is scattered
within the tissue and directed to APDs, which produced a train of TTL pulses that are fed
into the counting board, which stores them in an internal buffer. The normalized
autocorrelation curve is then computed.

The other advantage of developing a software correlator is that the photon count from each
detector can be recorded. This, in addition to the baseline autocorrelation data, was used to
measure the tissue optical properties as explained in the next section. Changes in the photon
count were also recorded during the ICG bolus tracking measurements. In this case, the
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temporal resolution was 300 ms and total acquisition time was 90 s. An intravenous bolus
injection ICG was given at the 10 s mark.

2.3.2

Time-Resolved NIRS

The TR-NIRS system utilized a picosecond diode laser emitting at 802 nm (LDH-P-C-810,
PicoQuant, Germany) (Figure 2-2). The output and pulse repetition rate of the laser were
set to 1.4 mW and 80 MHz, respectively, through a computer-controlled laser driver (PDL
828, PicoQuant). The light was coupled into a multimode fiber (NA = 0.22, core = 400 µm,
4.7 mm outer diameter; Fiberoptics Technology, US) and directed towards the head.
Reflected light was collected by a fiber bundle (core = 3600 µm, NA = 0.55, Fiberoptics
Technology, United States) placed 30 mm from the emission fiber on the piglet’s head.
The collected photons were then sent to a hybrid photomultiplier tube (PMA Hybrid 50,
PicoQuant, Germany), coupled to a HydraHarp 400 (PicoQuant, Germany) time-correlated
single photon counting module to record the arrival times of the photons. TPSFs were
computed using LabVIEW software. To measure the tissue optical properties, a TPSF was
acquired over a 60 s period. The temporal dispersion caused by the system was corrected
for by measuring the IRF. To avoid artifacts, such as instrument temporal drift, the TRNIRS system was allowed 1 h to warm up prior to the experiment.
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Figure 2-2: TR-NIRS system consisting of a 802 nm picosecond
laser placed 30 mm away from the detector on the piglet head.
Detected light from the PMTs is transferred to the computer for
computation of TPSFs.

2.4 Data Analysis
2.4.1

Measuring the Tissue Optical Properties by DCS and TRNIRS

To measure the tissue optical properties using MD-DCS, the effective attenuation
coefficient (µeff) was determined from the light intensity measurements acquired at the
different source-detector distances using the principals of spatially resolved NIRS, where
µeff is given by:

𝜇𝑒𝑓𝑓 = √(3𝜇 ′ 𝑠 (𝜆) ∙ 𝜇𝑎 (𝜆))

2-1
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µeff is the slope of intensity versus distance plot, as given by:
2
ln[𝑟𝑠𝑑
∙ 𝐼(𝑟)] = −𝜇𝑒𝑓𝑓 ∙ 𝑟𝑠𝑑 + 𝐼0 (0)

2-2

where, I(r) is the light intensity detected at a specific source-detector distance and I0 is the
light intensity at rsd = 0.
The next step was to fit the acquired normalized intensity autocorrelation (g2) curves,
which were generated by the software correlator by:

𝑔2 (∆n = τfs) =

〈𝑛(𝑖)𝑛(𝑖 + ∆𝑛)〉
〈𝑛(𝑖)〉〈𝑛(𝑖)〉
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where n(i) was the photon count at a time interval at index i on the internal buffer, fs is the
sampling frequency of the system operating at 1 MHz and ⟨⟩ represent the time averages
over navg = ntotal−∆n points. The g2 curves were fit using the solution to the correlation
diffusion equation for a semi-infinite homogeneous medium, assuming Brownian motion
of scatterers (as discussed in section 1.6):
3𝜇𝑠ʹ 𝑒 −𝑘𝐷𝑟1 𝑒 −𝑘𝐷𝑟2
𝐺1 =
(
−
)
4𝜋
𝑟1
𝑟2
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where kD2= µeff2 + 6µsʹk02αDB. The term DB is the blood flow index. The two fitting
parameters were µs and DB with µeff set to the value from the spatially resolved analysis.
The final step was to determine µa from Equation 2-1 using the estimates of µs and µeff.
To determine the optical properties by TR-NIRS, the measured TPSFs were fit using the
solution to the diffusion equation for semi-infinite homogeneous medium using
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extrapolated boundary conditions[34]. The IRF of the apparatus was also measured and
convolved with the analytical solution. A non-linear optimization routine was used to fit
the model convolved with the IRF to each measured TPSF [35]. All analyses were
conducted using the MATLAB function fminbound.

2.4.2

DCE Measurements of Absolute CBF

The procedure underlying the bolus tracking technique for quantifying the CBF is based
on measuring the change in signal intensity caused by the passage of ICG through the
microvasculature. This approach models the ICG passage as a linear time-invariant system.
That is, the time-varying concentration of ICG in tissue, C(t), is linearly proportional to its
concentration in arterial blood concentration, Ca(t), and CBF is assumed constant during
the measurement period, which is typically ~ 60 s. Based on these assumptions, C(t) is
related to Ca(t) by the convolution operator:
𝑡

𝐶(𝑡) = 𝐶𝐵𝐹 ∙ ∫ 𝐶𝑎 (𝑡 − 𝑢). 𝑅(𝑢)𝑑𝑢
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0

where R(t) is the impulse residue function, which represents the fraction of ICG in tissue
at time t following an ideal unit impulse injection at time t = 0. C(t) was determined from
intensity change due to the passage of ICG through the cerebral microvasculature as
recorded by the multi-distance DCS system, and Ca(t) was measured by the DDG (dye
densitogram) as outlined in Section 2.2. The flow-scaled impulse residue function,
CBF∙R(t), was extracted from Ca(t) and C(t) by performing a deconvolution and its initial
height is equivalent to CBF, since by definition R(0) = 1 [36].
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C(t) was determined using the solution to the diffusion approximation for a semi-infinite
medium to extract the time-varying change in absorption, µa(t), from the intensity
measurements at the largest source-detector distance:

𝐶(𝑡) =

[(𝜇𝑎 (𝑡) − 𝜇𝑎 (0))]
[ln(10) × 𝜀𝐼𝐶𝐺 ]
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where µa(0) represents the baseline absorption coefficient and εICG is the extinction
coefficient of ICG at 785 nm. The analysis required using the measured baseline optical
properties, µa and µs, as input parameters. For comparison, it was performed separately
using the estimated of µa and µs, from MD-DCS and from TR-NIRS. Changes in light
absorption due to ICG were characterized using µa as a fitting parameter, while keeping
µsfixed to the baseline value.

2.4.3

Dynamic CBF

To determine the change in CBF from baseline to either hyper or hypocapnia, each g2 curve
in the time series between levels was fit to extract the BFI (i.e., DB) as a function of time.
The value of CBF measured by the DCE method was used to convert the BF I time series
into units of CBF (ml/100g/min):

𝐶𝐵𝐹(𝑡) =

𝐵𝐹𝐼 (𝑡)
× 𝐶𝐵𝐹0
𝐵𝐹𝐼0
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where BFI(t) is the flow index at time t, BFI0 is the baseline value, and CBF0 is the value
of blood flow determined by the DCE method.
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2.5 Statistical Analysis
Statistical analyses were conducted using SPSS 17.0 (SPSS, Chicago, USA) and statistical
significance was described as p < 0.05. Linear regression analyses were conducted to
investigate the correlation between estimate of optical properties from TR-NIRS and MD
DCS as well as the CBF values derived from the two sets of optical properties. An analysis
of variance (ANOVA) was also used to determine the difference in optical properties
between techniques and conditions. Finally, the degree of similarity between CBF
measurements acquired by the two techniques was evaluated using a Bland-Altman plot
[37]
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Chapter 3

3

Results

3.1 Physiological Parameters
A total of 8 piglets were studied; however, one set was excluded due to poor quality of the
baseline autocorrelation curves, resulting in no convergence in the fitting. The poor quality
of this data set was attributed to poor contact of the probes on the piglet’s scalp. Average
values of the physiological parameters measured at each capnic condition from the seven
successful experiments (4 females, 3 males, mean weight = 3.02 ± 1.37 kg, mean age
= 6.7 ± 2.9 days) are summarized in Table 3-1.

Condition

paCO2

paO2

ctHb

HR

MAP

pH

(mmHg)

(mmHg)

(g/dL)

(bpm)

(mmHg)

Baseline

39±2

230±76

7.1±1.2

157±16

47±2

7.39±0.02

Hypercapnia

63±5*

120±26*

7.4±1.13

189±31*

49±4

7.24±0.03*

Hypocapnia

28±2*

284±74*

7.3±1.5

168±15*

46±3

7.52±0.02*

Table 3-1: Average physiological parameters ± standard deviation at baseline, hypercapnia
and hypocapnia. * indicates significant difference relative to the baseline value.
(pH = arterial pH; paCO2 = partial pressure of carbon dioxide in arterial blood; paO2 = partial pressure of
oxygen in arterial blood; ctHb = hemoglobin concentration; HR = heart rate; MAP = mean arterial pressure)
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Of all the measured parameters, significant differences were observed in paCO2, paO2, HR
and pH under both conditions relative to baseline, whereas no significant difference in
MAP or ctHb was noted under both conditions.

3.2 Optical Properties
Mean optical properties measured by MD-DCS and TR-NIRS are shown in Table 3-2. The
scattering coefficient was calculated at baseline only, whereas the absorption coefficient
was computed at baseline, hypercapnia and hypocapnia.
µsʹ (cm-1)

µa (cm-1)

Technique
Baseline

Baseline

Hypercapnia

Hypocapnia

TR-NIRS

7.51±1.59

0.11±0.02

0.13±0.02

0.12±0.01

MD-DCS

7.0±1.58

0.08±0.03

0.09±0.03

0.07±0.02

Table 3-2: Optical properties ± standard deviation calculated by TR-NIRS and MD-DCS
of 7 animals at 802 nm and 785 nm. Values are presented at baseline for µsʹ and at baseline,
hypercapnia and hypocapnia for µa.
Figure 3.1 shows the regression plot of the baseline µs values measured by TR-NIRS and
MD-DCS. The graph revealed a strong linear correlation (R2= 0.874) between the µsʹ values
from the two techniques with a slope of 0.93 and an intercept of 0.056 cm-1.
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Figure 3-1: Regression plot (filled circles) comparing µsʹ values measured by TRNIRS and MD-DCS. The solid line is the best-fit from linear regression (slope = 0.92,
intercept = 0.056 cm-1 and R2 = 0.87).
The correlation between mean values of the absorption coefficient measured by TR-NIRS
and MD-DCS at the three capnic conditions is shown in Figure 3-2. The results showed a
good correlation between the techniques (R2 = 0.70, slope = 0.89 and a yintercept = 0.048 cm-1).
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Figure 3-2: Regression plot of µa measured by TR-NIRS and MD-DCS under the 3
capnic levels. The dashed line is the best-fit from linear regression (slope = 0.89, intercept
= 0.048 cm-1 and R2 = 0.70). Data are presented as the mean ± standard error.

The multi-variate ANOVA revealed two statistical effects on µa across conditions
(baseline, hypercapnia and hypocapnia) and techniques (MD-DCS and TR-NIRS). That is,
µa was significantly different across the three conditions (F2,12 = 35.25, p<0.05) and
significantly different between techniques (F1,6 = 7.7, p<0.05).

3.3 DCS and DCE Data Under Different Flow Conditions
Measured normalized intensity autocorrelation functions and corresponding tissue ICG
curves from one animal are shown in Figure 3.3. Data from each technique are shown under
the three flow conditions: baseline, hypercapnia and hypocapnia. As expected, when CBF
increased the autocorrelation curve decayed faster and visa-versa when blood flow
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decreased. A similar trend was observed with the ICG tissue concentration curves. That is,
the peak and initial rise of the first pass time both increased as CBF increased going from
hypocapnia to hypercapnia.

Figure 3-3: (A) Typical normalized intensity autocorrelation functions and (B) the
corresponding tissue ICG curves measured at baseline, hypercapnia and hypocapnia
in one animal. Each curve in (A) was obtained by averaging a set of curves over a
2 minute acquisition period.

3.4 CBF Measurements
Mean CBF values obtained from the DCE data using baseline optical properties measured
by TR-NIRS and MD-DCS are shown in Table 3-3 for the three capnic conditions. Figure
3-4 shows the regression plot between the two sets of CBF values. A strong correlation
was found with an R2 = 0.924, slope of 0.91 and y-intercept of 4.27 ml/100g/min. The
results of a multi-variate ANOVA revealed significant differences in CBF across
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conditions (F2,12 = 14.314 and p<0.05), but no significant difference between CBF values
obtained with the two sets of optical properties.

Condition
Technique

CBFTR-NIRS
(ml/100g/min)
CBFMD-DCS
(ml/100g/min)

Baseline

Hypercapnia

Hypocapnia

28.03±14.43

37.31±10.63

19.69±6.25

26.34±14.70

35.54±12.32

17.44±6.58

Table 3-3: CBF values (mean ± standard deviation) calculated for 7 animals
under baseline, hypercapnia and hypocapnia from optical properties derived
from TR-NIRS and MD-DCS.
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Figure 3-4: Regression values comparing CBF values derived from DCE data using
optical properties from TR-NIRS and MD-DCS
Figure 3-5 shows the Bland-Altman plot comparing the two sets of CBF measurements.
The mean difference between both the techniques was 1.9 ml/100g/min, which was bound
by 95% confidence intervals of -5.77 and 9.58 ml/100g/min.
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Figure 3-5: Bland-Altman plot comparing the CBF measurements obtained using
baseline optical properties from TR-NIRS and MD-DCS. Mean difference between the
two methods is indicated by the solid line and the 95% confidence interval is demarcated
by the dashed line.

3.5 Flow Changes During Change in Capnic Level:
Illustrative plots of the temporal change in absolute CBF during the transitions from
baseline to hypercapnia and to hypocapnia are shown in Figure 3-6. These CBF time plots
are from separate animals and in each case the relative change in the blood flow index was
converted to units of absolute CBF using a single baseline DCE measurement. The changes
in blood flow from baseline to hypercapnia were more rapid than the corresponding change
from baseline to hypocapnia because of the difference in how each capnic condition was
induced. That is, hypercapnia was achieved by incorporating a small fraction of CO2 into
the breathing circuit, while hypocapnia was induced by hyperventilation.
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Figure 3-6: CBF time course during (A) a hypercapnia challenge and (B) a
hypocapnic challenge of two animals. The vertical dotted line at 5 minutes
indicates the end of baseline and start of the capnic challenge.
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Chapter 4

4

Discussion

In this thesis, the development of a DCS system capable of measuring absolute CBF was
presented. The key modification to an existing DCS system [24] was replacing a
commercial hardware correlator with an in-house-developed software version that enabled
the acquisition of light intensity and autocorrelation functions at multiple source-detector
distances. The concept of using a software correlator for DCS was initially purposed to
optimize the measured correlation times, thereby provided faster acquisition times
[32],[38]. In this study, switching to a software correlator provided the ability to record
light intensity, which was used to track the temporal changes in absorption caused by the
passage of ICG through the cerebral vasculature. These changes were subsequently
converted to a tissue ICG concentration curve using the baseline optical properties (a and
µs) derived by a combination of spatially resolved light intensity measurements and
normalized intensity autocorrelation functions. The data presented in Figure 3.3
demonstrated that this approach could produce ICG concentration curves with high contrast
to noise and was sensitive to blood flow changes. A previously validated deconvolution
routine [23] was used to extract CBF from the recorded tissue and arterial ICG
concentration curves. As a final step, the derived CBF value was used to convert relative
blood flow data determined by DCS into units of absolute flow (e.g. Figure 3.6).
The concept of combining bolus-tracking and DCS techniques was first proposed by Diop
et al. [23]. Using the same animal model as in the current study (newborn piglets), a strong

43

linear correlation between CBF measured by DCE-NIRS and the BFI measured by DCS
was reported (R2 = 0.93) over a flow range from 17 to 90 ml/100g/min. This study
highlighted the value of combining a quantitative NIRS method – in this case TR-NIRS –
with DCS, as NIRS could be used to obtain the tissue optical properties and conduct a DCE
experiment to determine CBF. The limitation was the need to combine two optical
methods, which increases costs and the overall complexity of the system [23]. The MDDCS approach developed in this thesis offers a less expensive and simpler alternative for
monitoring CBF. Furthermore, it avoids any potential partial volume errors between
optodes from separate systems and ensures the optical properties are measured at the same
wavelength as the DCS data are acquired.
The first study to propose using MD-DCS to measure BFi, µsʹ and µa was by Farzam et al.
The idea was MD measurements would provide sufficient additional information to extract
all three parameters. However, the signal-to-noise required to avoid crosstalk between the
three fitting parameters limited the techniques to small source-detector separations (<2 cm)
[39]. Recently, Tamborini et al. expanded this idea by acquired DCS data at both multiple
wavelengths and source-detector separations to measure blood oxygenation and BFI.
Estimates of five fitting parameters (BFI, two scattering terms, and concentrations of HbO
and Hb) were obtained from a single cost function that included measurements of
correlations times and light intensity at four source-detector distances and two
wavelengths. Experiments involving tissue mimicking phantoms were used to demonstrate
the importance of using both multi-distance and multi-wavelength measurements to
accurately measure all fitting parameters, particularly s´ [40].
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The current study followed a similar approach to Tamborini et al. by collecting intensity
and correlation measurements at multiple source-detector distances. However, the focus
was solely on measuring the baseline optical properties to derive tissue ICG concentration
curves and not on estimating tissue oxygenation. Consequently, data were only recorded at
a single wavelength, reducing the number of unknowns to BFI, a and s´. In addition, the
two studies differed in how the MD intensity and correlation measurements were
combined. In the current study, a three-step procedure was implemented: First,eff was
extracted from the MD intensity measurements, analogous to spatially resolved NIRS.
Next, the intensity autocorrelation curves obtained at multiple source-detector distances
were fit with the diffusion approximation (Equation 1.24), which involved only two
parameters (s´ and BFI) since eff was determined in the first step. Finally, a was
estimated using Equation 2.1. The strong correlation between s´ estimates obtained by
MD-DCS and TR-NIRS (figure 3.1) demonstrated that the former can measure s´, despite
the prediction by Tamborini et al. that data from multiple wavelengths are required. This
is likely due to the difference in the number of fitting parameters used in the two
approaches.
A correlation between a estimates from MD-DCS and TR-NIRS (Figure 3.2) was also
found; however, the a values from MD-DCS were significantly lower than the
corresponding TR-NIRS estimates, and the between-subject variation was approximately
70% greater for MD-DCS (Table 3.2). The most likely cause was errors in eff considering
the good agreement between s´ estimates from the two techniques. The primary
assumptions of spatially resolved NIRS are that the tissue can be modelled as a semi-
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infinite medium and the reflectance measurements are acquired on a flat surface. It is
known that extracerebral tissues (scalp and skull) as well as cerebrospinal fluid in the
subarachnoid space can affect the accuracy of spatially resolved measurements; however,
the impact with respect to measurements on the piglet head should be minimal considering
the depth to the brain from the skin surface is less than 3 mm [41]. The assumption of
planer geometry can be violated if there is noticeable curvature to the head [42]. In the
piglet experiments, the probes were positioned anteroposterior on one side of the head to
achieve as closely as possible the required probe geometry. However, the dimensions of
the piglet’s cranium are relatively small and, therefore, some deviation was possible.
Despite the discrepancy in a values between the two NIRS techniques, the CBF estimates
obtained by analyzing the DCE data using the two sets of optical properties (Figure 3-4)
were strongly correlated (R2 = 0.92) and the mean bias from the Bland-Altman analysis
was small (1.9 ml/100g/min). Furthermore, the variability between animals under each
capnic condition was similar for the two sets of optical properties (Table 3-3). The CBF
estimates did not show the variability observed with a because the diffusion equation
(Equation.1-16) used to obtain tissue ICG concentration curves is primarily dependent on

s´ and eff, and the latter is proportional to the square root of a. These results indicate that
the accuracy of the optical properties obtained from MD-DCS was sufficient for estimating
CBF and a separate NIRS system specifically for measuring baseline a and s´ is not
necessary.
A potential complication with combining DCS with a bolus-tracking method is the effects
of ICG on μa, which can affect BFI measurements. To minimize this effect, each ICG
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injection was followed by a 15-min delay to allow sufficient time for the dye to clear from
the circulation. Previous experiments showed that the change in µa after the first pass of
ICG is typically around 5%, which would translate into a 2% error in BFI [23].
There are a number of potential limitations with this study. First, the optical properties
measured by the two techniques were not at the same wavelength: TR-NIRS acquired data
at 802 nm while and DCS measurements were at 785 nm. A previous study reported that
this wavelength difference would lead to differences in optical properties of the order of
5% [23]. Second, TR-NIRS was only used to measure µa and µsʹ, and not to acquire a
separate set of ICG concentration curves. The latter was not performed because the most
direct means of measuring the absorption effects caused by the passage of ICG is by
measuring the changes in light intensity. In contrast, TR-NIRS requires careful attention to
ensure a linear relationship between dynamic absorption changes and the recorded
distributions of times of flight [23].
Another potential limitation with the study was that hypercapnia was induced by adding
6% CO2 to the inhaled gas mixture rather than altering the animal’s breathing rate and
volume, such as performed to induced hypocapnia. The former was conducted in order to
elicit a rapid increase in paCO2, which in turn would lead to a rapid CBF response.
However, introducing the CO2 tank into the breathing circuit required reducing the O2 flow,
which resulted in a significant drop in paO2 relative to baseline (Table 3-1). Despite this
decrease, paO2 remained within normal limits and its effects on CBF would be small
relatively to the large increase in paCO2.
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Chapter 5

5

Conclusions and Future Work

Based on the objective of developing a stand-alone DCE system capable of monitoring
absolute CBF, I have:
1. Developed software to record intensity data and generate autocorrelation functions.
2. Modified a DCS system to record data at multiple distances using a multi-channel
counter system.
3. Demonstrated the ability of the MD-DCS system to measure tissue optical
properties, which were validated against TR-NIRS.
4. Presented experimental data results showing how the developed system can
quantify CBF using a bolus tracking technique and can track changes in CBF.
Based on these results, a potential next step would be to conduct a clinical study to
determine blood flow thresholds that are related to brain injury in preterm infants under
intensive care. This would be analogous to studies of ischemic stroke in the mature brain
that have shown that the extent of brain injury is related to both the drop in CBF and the
duration of ischemia. Regarding neonatal brain injury, the goal would be to determine if
there are flow thresholds in terms of the magnitude of the decrease in CBF and its duration
that can be related to risk of brain injury (either IVH or PVL) developing. It is important
to realize that normal CBF is considerably lower in the preterm brain relative to the mature
brain and consequently specifically ischemic thresholds remain unknown in this
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population. Hopefully, the MD-DCS approach developed in this work could help
established critical ischemic thresholds.
An additional application of the MD-DCS system would be to use the improved temporal
resolution provided by the software-correlator to capture flow pulsatility. Analogous to
approaches based on transcranial Doppler, DCS measurements of flow pulsatility can be
used to assess the critical closing pressure, which is the value of the arterial blood pressure
at which CBF approaches zero [43] The procedure does require blood pressure monitoring,
which is performed in the neonatal intensive care unit. Investigating critical closing
pressure in preterm infants has not seen a lot of attention, likely due in part to the lack of a
suitable neuromonitoring technique.
The developed MD-DCS system used a single wavelength to measure the optical properties
and CBF. Recent studies have shown that total hemoglobin concentration and oxygen
saturation can be extracted by collecting DCS data at multiple wavelengths [40]. However,
this requires developing a suitable laser drive to cycle between the two lasers that must
provide suitable coherence to perform correlation analysis.
Finally, the present system targets neonates, who have negligible extracerebral signal
contamination. Adapting this technology to adults would be challenging due to presence
of extracerebral tissues that are of the order of 1 to 1.5 cm thick. The spatially resolved
approach used to compute µeff is invalid for the adult head and therefore, translating this
technology to adults would require an alternative approach. Recently, the concept of TRDCS was proposed to combine DCS with the improved depth sensitivity of TR detection
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[44]. However, the required technology is currently complex and requires more
development.
In summary, the ability to continuously measure absolute flow could help improve the
outcome of patients at risk of brain injury by early identification of abnormal CBF.

50

References
[1]

R. E. Behrman and A. S. Butler, Eds., Preterm Birth: Causes, Consequences, and
Prevention. Washington (DC), (2007).

[2]

A. B. J. Stoll, N. I. Hansen, B. B. Poindexter, and N. N. Finer, “Neonatal
Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research
Network,” 126, (3), pp. 443–456, 2010.

[3]

S. Noori and I. Seri, “Hemodynamic antecedents of peri / intraventricular
hemorrhage in very preterm neonates,” Semin. Fetal Neonatal Med., 20, (4),pp.
232–7, 2015.

[4]

Q. Shang, C.-Y. Ma, N. Lv, Z. Lv, Y. Yan, Z.-R. Wu, J.-J. Li, J.-L. Duan, and C.L. Zhu, “Clinical study of cerebral palsy in 408 children with periventricular
leukomalacia,” Exp Ther Med, 9, (4), pp. 1336–1344, 2015.

[5]

G. Greisen, “Autoregulation of cerebral blood flow in new born babies.” Early
Human development, 81, (5)pp. 423–428, 2005.

[6]

E. S. Peeples, E. Mehic, P. D. Mourad, and S. E. Juul, “Fast Doppler as a novel
bedside measure of cerebral perfusion in preterm infants.,” Pediatr. Res., 79, (2),
pp. 333–338, Feb. 2016.

[7]

L. Vutskits, “Cerebral blood flow in the neonate,” Paediatr Anaesth, 24, (1), 2013.

[8]

J. H. Meek, L. Tyszczuk, C. E. Elwell, and J. S. Wyatt, “Low cerebral blood flow
is a risk factor for severe intraventricular haemorrhage,” Arch Dis Child Fetal
Neonatal Ed, 81, (1)pp. 18–21, 1999.

[9]

J. S. Soul, P. E. Hammer, M. Tsuji, J. P. Saul, H. Bassan, C. Limperopoulos, D. N.
Disalvo, M. Moore, P. Akins, S. Ringer, J. J. Volpe, J. Du Plessis, and F.
Trachtenberg, “Fluctuating Pressure-Passivity Is Common in the Cerebral
Circulation of Sick Premature Infants,” 61, (4), 2007.

[10] W.-D. Heiss, “The ischemic penumbra: how does tissue injury evolve?,” Ann. N.
Y. Acad. Sci., 1268, pp. 26–34, Sep. 2012.
[11] F. F. Jobsis, “Noninvasive, infrared monitoring of cerebral and myocardial oxygen
sufficiency and circulatory parameters.,” Science, 198, (4323), pp. 1264–1267,
Dec. 1977.
[12] T. Durduran, R. Choe, W. B. Baker, and A. G. Yodh, “Diffuse Optics for Tissue
Monitoring and Tomography,” Rep. Prog. Phys., 73, (7), p. 76701, Jul. 2010.
[13] R. Bonner and R. Nossal, “Model for laser Doppler measurements of blood flow in
tissue,” Appl. Opt., 20, (12), pp. 2097–2107, 1981.
[14] A. Ishimaru, “Diffusion of light in turbid material.,” Appl. Opt., 28, (12), pp.
2210–2215, Jun. 1989.
[15] W. B. Baker, A. B. Parthasarathy, D. R. Busch, R. C. Mesquita, J. H. Greenberg,
and A. G. Yodh, “Modified Beer-Lambert law for blood flow,” 5, (11), pp. 4407–

51

4424, 2014.
[16] A. Ghosh, C. Elwell, and M. Smith, “Review article: cerebral near-infrared
spectroscopy in adults: a work in progress.,” Anesth. Analg., 115, (6), pp. 1373–
1383, Dec. 2012.
[17] A. Siegel, J. J. Marota, and D. Boas, “Design and evaluation of a continuous-wave
diffuse optical tomography system.,” Opt. Express, 4, (8), pp. 287–298, Apr. 1999.
[18] S. Matcher, P. Kirkpatrick, K. Nahid, M. Cope, and D. T. Delpy, “Absolute
quantification methods in tissue near-infrared spectroscopy, ” Proc SPIE 2389.
(1995).
[19] H. Liu, D. A. Boas, Y. Zhang, A. G. Yodh, and B. Chance, “Determination of
optical properties and blood oxygenation in tissue using continuous NIR light.,”
Phys. Med. Biol., 40, (11), pp. 1983–1993, Nov. 1995.
[20] D. T. Delpy, M. Cope, P. van der Zee, S. Arridge, S. Wray, and J. Wyatt,
“Estimation of optical pathlength through tissue from direct time of flight
measurement.,” Phys. Med. Biol., 33, (12), pp. 1433–1442, Dec. 1988.
[21] B. Montcel, R. Chabrier, and P. Poulet, “Detection of cortical activation with timeresolved diffuse optical methods.,” Appl. Opt., 44, (10), pp. 1942–1947, Apr.
2005.
[22] S. Fantini and M. A. Franceschin, “Frequency-domain techniques for tissue
spectroscopy and imaging,” in Handbook of optical biomedical diagnostics,
(2002), pp. 405–443.
[23] M. Diop, K. Verdecchia, T.-Y. Lee, and K. St Lawrence, “Calibration of diffuse
correlation spectroscopy with a time-resolved near-infrared technique to yield
absolute cerebral blood flow measurements,” Biomed. Opt. Express, 2, (7), p.
2068, 2011.
[24] Guoqiang Yu; Durduran, Turgut; Zhou, Chao; Cheng, Ran; Yodh, “Near-Infrared
Diffuse Correlation Spectroscopy for Assessment of Tissue Blood Flow,” in
Handbook of biomedical optics, (2005), pp. 195–216.
[25] D. A. Boas, L. E. Campbell, and A. G. Yodh, “Scattering and Imaging with
Diffusing Temporal Field Correlations,” Phys. Rev. Lett., 75, (9), pp. 1855–1858,
Aug. 1995.
[26] D. A. Boas and A. G. Yodh, “Spatially varying dynamical properties of turbid
media probed with diffusing temporal light correlation,” 14, (1), pp. 192–215,
1997.
[27] S. E. Skipetrov and R. Maynard, “Dynamic multiple scattering of light in
multilayer turbid media,” Phys. Lett. A, 217, (2), pp. 181–185, 1996.
[28] K. Verdecchia, M. Diop, L. B. Morrison, T.-Y. Lee, and K. St. Lawrence,
“Application of a Three-Layer Model to Multi-Distance Diffuse Correlation
Spectroscopy: Validation Experiments in Pigs,” in Biomedical Optics 2016,
(2016), p. JW3A.40.

52

[29] K. Verdecchia, M. Diop, A. Lee, B. Morrison, Laura, T.-Y. Lee, and K. St.
Lawrence, “Assessment of a multi-layered diffuse correlation spectroscopy
method for monitoring cerebral blood flow in adults,” 7, (9), pp. 1951–1958, 2016.
[30] K. Schätzel, “Correlation techniques in dynamic light scattering,” Appl. Phys. B,
42, (4), pp. 193–213, 1987.
[31] D. Magatti and F. Ferri, “Fast multi-tau real-time software correlator for dynamic
light scattering,” 40, (24), pp. 4011–4021, 2001.
[32] D. Wang, A. B. Parthasarathy, W. B. Baker, K. Gannon, V. Kavuri, T. Ko, S.
Schenkel, Z. Li, Z. Li, M. T. Mullen, J. A. Detre, and A. G. Yodh, “Fast blood
flow monitoring in deep tissues with real-time software correlators,” Biomed. Opt.
Express, 7, (3), p. 776, 2016.
[33] G. Dietsche, M. Ninck, C. Ortolf, J. Li, F. Jaillon, and T. Gisler, “Fiber-based
multispeckle detection for time-resolved diffusing-wave spectroscopy:
characterization and application to blood flow detection in deep tissue.,” Appl.
Opt., 46, (35), pp. 8506–8514, Dec. 2007.
[34] A. Kienle and M. S. Patterson, “time-resolved diffusion equations for reflectance
from a semi-infinite turbid medium,” 14, (1), pp. 246–254, 1997.
[35] A. Liebert, H. Wabnitz, D. Grosenick, and R. Macdonald, “Fiber dispersion in
time domain measurements compromising the accuracy of determination of optical
properties of strongly scattering media.,” J. Biomed. Opt., 8, (3), pp. 512–516, Jul.
2003.
[36] D. W. Brown, P. A. Picot, J. G. Naeini, R. Springett, D. T. Delpy, and T.-Y. Lee,
“Quantitative near infrared spectroscopy measurement of cerebral hemodynamics
in newborn piglets.,” Pediatr. Res., 51, (5), pp. 564–570, May 2002.
[37] J. M. Bland and D. G. Altman, “Statistical methods for assessing agreement
between two methods of clinical measurement.,” Lancet (London, England), 1,
(8476), pp. 307–310, Feb. 1986.
[38] D. Magatti, F. Ferri, and I. Introduction, “25 ns software correlator for photon and
fluorescence correlation spectroscopy,” 74, (2), pp. 1135–1144, 2003.
[39] P. Farzam and T. Durduran, “Multidistance diffuse correlation spectroscopy for
simultaneous estimation of absolute scattering and absorption coefficient and the
blood flow index,” J. Biomed. Opt., 20, (5), p. 55001, 2015.
[40] D. Tamborini, P. Farzam, B. Zimmermann, K.-C. Wu, D. A. Boas, and M. A.
Franceschini, “Development and characterization of a multidistance and
multiwavelength diffuse correlation spectroscopy system,” Neurophotonics, 5, (1),
p. 1, 2017.
[41] M. Diop, J. T. Elliott, K. M. Tichauer, T.-Y. Lee, and K. St Lawrence, “A
broadband continuous-wave multichannel near-infrared system for measuring
regional cerebral blood flow and oxygen consumption in newborn piglets.,” Rev.
Sci. Instrum., 80, (5), p. 54302, May 2009.
[42] M. Dehaes, L. Gagnon, F. Lesage, M. Pelegrini-Issac, A. Vignaud, R. Valabregue,

53

R. Grebe, F. Wallois, and H. Benali, “Quantitative investigation of the effect of the
extra-cerebral vasculature in diffuse optical imaging: a simulation study.,”
Biomed. Opt. Express, 2, (3), pp. 680–695, Feb. 2011.
[43] R. B. Panerai, “The critical closing pressure of the cerebral circulation.,” Med.
Eng. Phys., 25, (8), pp. 621–632, Oct. 2003.
[44] J. Sutin, B. Zimmerman, D. Tyulmankov, D. Tamborini, K.-C. Wu, J. Selb, A.
Gulinatti, I. Rech, A. Tosi, D. A. Boas, and M. A. Franceschini, “Time-domain
diffuse correlation spectroscopy,” 3, (9), 2016.

54

Appendix A
The software correlator used in this thesis was adapted from the work presented by Wang
et al [32]. It was implemented on a standard personal computer using a PCIe 6612
counter/timer data acquisition board (National instruments, Texas, US) and a customized
software program (LabVIEW, National Instruments, Texas, US). As shown in the
schematic below, the digital pulses from each of the three channels generated by the photon
counting APDs were transferred to three of the 8 edge-detecting photon counters on the
PCIe board. The counters were synchronized by an internal timebase of 80 MHz, which
updated its internal count by one when a TTL pulse was detected. These counts were then
transferred to the internal buffer at a pre-defined sampling frequency of 1 MHz, which
defines the bin width of the internal buffer (fs=1/Δt). The counts were stored in the buffer
(N(i)) at a pre-set temporal resolution of 300 ms given by tint. The number of points on the
buffer (nint = fs × tint) were transferred to the computer for storage, which were subsequently
used to compute the autocorrelation function at each source-detector distance using
Equation 2-3. The LabVIEW software computed the normalized intensity autocorrelation
in real time using a buffered producer-consumer loop over 40 delay times that ranged from
1 to 30 µs.

Figure L-1: Schematic of the software correlator operation
showing the counter operation in the PCIe-6612 data
acquisition board. (Adapted from Wang et al. 2016)
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